Cargando…

Older Age and Steroid Use Are Associated with Increasing Polypharmacy and Potential Medication Interactions Among Patients with Inflammatory Bowel Disease

BACKGROUND: Comorbidity and polypharmacy, more prevalent among older persons, may impact the treatment of patients with inflammatory bowel disease (IBD). The aims of this study were to assess the frequency of polypharmacy and medication interactions within a cohort of older patients with IBD and des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parian, Alyssa, Ha, Christina Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Original Clinical Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450972/ https://www.ncbi.nlm.nih.gov/pubmed/25856768 http://dx.doi.org/10.1097/MIB.0000000000000391

Ejemplares similares

Gender differences, polypharmacy, and potential pharmacological interactions in the elderly
por: Venturini, Carina Duarte, et al.
Publicado: (2011)

Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
por: Chen, Zhaoyan, et al.
Publicado: (2023)

Trends in polypharmacy and potentially inappropriate medication (PIM) in older and middle‐aged people treated for diabetes
por: Oktora, Monika Pury, et al.
Publicado: (2020)

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
por: Fleisher, Mark, et al.
Publicado: (2018)

Polypharmacy in the Older Adult: Medication Review in the Community
por: Pacetti, Staci, et al.
Publicado: (2020)

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy
por: Siefried, Krista J., et al.
Publicado: (2018)

Low Incidence of Dysplasia and Colorectal Cancer Observed among Inflammatory Bowel Disease Patients with Prolonged Colonic Diversion
por: Bettner, Weston, et al.
Publicado: (2018)

Comparing Effects of Polypharmacy on Inflammatory Profiles in Older Adults and Mice: Implications for Translational Aging Research
por: Wu, Harry, et al.
Publicado: (2022)

Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment
por: Ramsdale, Erika, et al.
Publicado: (2022)

Polypharmacy and potentially inappropriate medications (PIMs) in older adults referred to a memory clinic
por: Akpan, Anietie, et al.
Publicado: (2021)

The Burden of Potentially Inappropriate Medications in Chronic Polypharmacy
por: Guillot, Jordan, et al.
Publicado: (2020)

Polypharmacy and Potentially Inappropriate Medications in Patients With Dementia
por: Nonaka, Ryo, et al.
Publicado: (2020)

Polypharmacy in Patients With Inflammatory Bowel Disease: Prevalence and Outcomes in a Single-center Series
por: Mesonero, Francisco, et al.
Publicado: (2022)

Medication transitions and polypharmacy in older adults following acute care
por: Gamble, John-Michael, et al.
Publicado: (2014)

Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Frey, Sarah, et al.
Publicado: (2022)

Use of potentially inappropriate medication and polypharmacy in older adults: a repeated cross-sectional study
por: Thorell, Kristine, et al.
Publicado: (2020)

Polypharmacy and potentially inappropriate medications (PIMS) in older adults referred to a liaison psychiatry service
por: Akpan, Anietie, et al.
Publicado: (2021)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
por: Krečak, Ivan, et al.
Publicado: (2023)

Fr500 COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Sa1064: IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A LOCAL REPORT
por: Tsipotis, Evangelos, et al.
Publicado: (2022)

Increasing Trends of Polypharmacy and Potentially Inappropriate Medication Use in Older Lung Cancer Patients in China: A Repeated Cross-Sectional Study
por: Tian, Fangyuan, et al.
Publicado: (2022)

Indirect and Direct 65+ Patient Reporting of Non-Steroidal Anti-Inflammatory Drug-Induced Adverse Drug Reactions as a Source of Information on Polypharmacy and Polypharmacy-Related Risk
por: Sienkiewicz, Kamila, et al.
Publicado: (2023)

Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
por: Klein, Amir, et al.
Publicado: (2010)

Old age, high risk medication, polypharmacy: a ‘trilogy’ of risks in older patients with atrial fibrillation
por: Wang., Yishen, et al.
Publicado: (2016)

Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
por: Sheikh-Taha, Marwan, et al.
Publicado: (2021)

Polypharmacy and Potential Drug–Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study
por: Hermann, Monica, et al.
Publicado: (2021)

Inappropriate Medications Use and Polypharmacy among Older Adults with Anxiety Disorder
por: Alwhaibi, Monira
Publicado: (2023)

Polypharmacy among HIV infected people aged 50 years or older
por: Fernández Cañabate, Sonia, et al.
Publicado: (2019)

Polypharmacy and potentially inappropriate medications among hospitalized older adults with COVID-19 in Malaysian tertiary hospitals
por: Chang, Chee-Tao, et al.
Publicado: (2023)

Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes
por: Lu, Lvliang, et al.
Publicado: (2023)

Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis
por: Sagoe, Dominic, et al.
Publicado: (2015)

Polypharmacy in Older Adults with Alzheimer’s Disease
por: Esumi, Satoru, et al.
Publicado: (2022)

Pharmacologic therapy for inflammatory bowel disease refractory to steroids
por: Martínez-Montiel, MP, et al.
Publicado: (2015)

2325: Steroid therapy limits stem cell activation required to enact mucosal healing in inflammatory bowel disease
por: Brady Lynch, Evan, et al.
Publicado: (2018)

Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010–2019
por: Cho, Ho Jin, et al.
Publicado: (2022)

Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis
por: Zhao, Mengnan, et al.
Publicado: (2023)

Polypharmacy and Hyperpolypharmacy in Older Individuals with Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Bhagavathula, Akshaya Srikanth, et al.
Publicado: (2022)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

High-Risk Medication Use and Polypharmacy in Older Veterans Who Attempt Suicide
por: Morin, Ruth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7k51tatltkp7848r7mmcqn6tmc